PCM

Penserra Capital Management Portfolio holdings

AUM $7.17B
1-Year Return 49.58%
This Quarter Return
+4.69%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$73.4M
Cap. Flow %
-1.57%
Top 10 Hldgs %
14.09%
Holding
1,668
New
221
Increased
658
Reduced
448
Closed
328

Sector Composition

1 Technology 30.99%
2 Consumer Discretionary 19.93%
3 Communication Services 10.14%
4 Financials 6.24%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALGN icon
1551
Align Technology
ALGN
$9.76B
-8,266
Closed -$5.5M
ALKS icon
1552
Alkermes
ALKS
$4.77B
-3,685
Closed -$113K
ALLK
1553
DELISTED
Allakos
ALLK
-1,235
Closed -$130K
ALLO icon
1554
Allogene Therapeutics
ALLO
$246M
-3,255
Closed -$83K
ALT icon
1555
Altimmune
ALT
$314M
-910
Closed -$10K
ALXO icon
1556
ALX Oncology
ALXO
$57.8M
-925
Closed -$68K
AMPH icon
1557
Amphastar Pharmaceuticals
AMPH
$1.36B
-1,100
Closed -$20K
AMRN
1558
Amarin Corp
AMRN
$311M
-446
Closed -$45K
ANAB icon
1559
AnaptysBio
ANAB
$590M
-630
Closed -$17K
ANIP icon
1560
ANI Pharmaceuticals
ANIP
$2.08B
-290
Closed -$9K
ANNX icon
1561
Annexon
ANNX
$236M
-875
Closed -$16K
APLS icon
1562
Apellis Pharmaceuticals
APLS
$3.62B
-1,990
Closed -$65K
APLT icon
1563
Applied Therapeutics
APLT
$67M
-595
Closed -$9K
APRE icon
1564
Aprea Therapeutics
APRE
$8.74M
-25
Closed -$2K
ARCT icon
1565
Arcturus Therapeutics
ARCT
$455M
-605
Closed -$28K
ARDX icon
1566
Ardelyx
ARDX
$1.58B
-2,365
Closed -$3K
ARES icon
1567
Ares Management
ARES
$39.5B
-19,080
Closed -$1.41M
ARQT icon
1568
Arcutis Biotherapeutics
ARQT
$1.94B
-1,155
Closed -$27K
ARVN icon
1569
Arvinas
ARVN
$559M
-1,125
Closed -$92K
ASAN icon
1570
Asana
ASAN
$3.44B
-85,569
Closed -$8.89M
ASMB icon
1571
Assembly Biosciences
ASMB
$179M
-86
Closed -$3K
ATKR icon
1572
Atkore
ATKR
$1.96B
-115,008
Closed -$10M
ATRA icon
1573
Atara Biotherapeutics
ATRA
$89.9M
-78
Closed -$34K
AUPH icon
1574
Aurinia Pharmaceuticals
AUPH
$1.65B
-2,945
Closed -$65K
AUTL
1575
Autolus Therapeutics
AUTL
$386M
-1,305
Closed -$8K